# GLOBUS MEDICAL INC (GMED) — Stock CV

Globus Medical Inc is a $9.95B healthcare company. Revenue grew 19.7% over the last year, and it keeps 17¢ of every dollar of sales as profit. It trades at 18.7× earnings — near the lowest of its own history.

> Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers.

## Identity

- **Ticker**: GMED
- **Sector**: Healthcare
- **Industry**: Surgical & Medical Instruments & Apparatus
- **Headquarters**: AUDUBON, PA
- **Employees**: 6 000
- **Website**: https://www.globusmedical.com
- **Market cap**: $9.95B
- **Last price**: $74.10
- **Financial profile**: Strong

## Vitals (TTM)

- **Revenue**: $3.14B
- **Net income**: $535M
- **Free cash flow**: $756M
- **P/E**: 18.7
- **Revenue growth (YoY)**: 19.7%

## Skills (profile scores, 0–100)

| Pillar | Score |
|---|---|
| Valuation | 85 |
| Growth | 95 |
| Profitability | 64 |
| Health | 60 |
| Quality | 95 |
| Moat | 68 |

## Qualifications (beginner checklist) — 9 of 10 passed

- [x] Revenue growing — +19.7% YoY
- [x] Profitable — $535M TTM
- [x] Profit growing — +28.4% YoY
- [x] Generates cash — $756M TTM
- [x] Debt under control — current ratio 4.62
- [x] Established company — $9.95B market cap
- [ ] Not printing shares — +35.7% shares over ~5y
- [x] Proven track record — 10/10 profitable years
- [x] Financially stable — Altman Z 9.6 — safe
- [x] Valuation not extreme — P/E 18.7

## Experience (career milestones)

- **FY2025** — Best year on record: $538M net income
- **FY2022** — Revenue crossed $1B: $1.02B for the year
- **FY2016** — Profitable every year on record: 10 consecutive profitable years in our data
- **FY2016** — Positive free cash flow every year since: 10-year streak

## Strengths

- High gross margin (68.5%)
- Revenue growing 19.7% year over year
- Strong cash conversion — FCF is 24.0% of revenue
- Piotroski F-Score 9/9 — fundamentally strong checklist
- Altman Z-Score 9.56 — low bankruptcy-risk zone

## Watch-outs

- None stand out in the data.

## Track record

| Year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| FY2021 | $958M | $149M | $219M |
| FY2022 | $1.02B | $190M | $104M |
| FY2023 | $1.57B | $123M | $165M |
| FY2024 | $2.52B | $103M | $405M |
| FY2025 | $2.94B | $538M | $589M |

---

Source: https://stockcv.com/GMED — derived from company filings; may be delayed or incomplete. Information, not investment advice.